Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Multikine
Other

Multikine

Tracked across 1 events · 6 articles · First seen May 12, 2026 · Last active May 13, 2026

Sentiment
0
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 0
Business
CEL-SCI Closes Public Offering
Impact: The proceeds from CEL-SCI Corporation's offering will be used for the continued development of Multikine, an investigational cancer immunotherapy.
May 12, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Multikine live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.